Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:TCDA

Tricida (TCDA) Stock Price, News & Analysis

Tricida logo

About Tricida Stock (NASDAQ:TCDA)

Key Stats

Today's Range
N/A
50-Day Range
$0.11
$0.19
52-Week Range
N/A
Volume
31.13 million shs
Average Volume
17.62 million shs
Market Capitalization
$6.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Tricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker on May 22, 2013 and is headquartered in South San Francisco, CA.

Receive TCDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tricida and its competitors with MarketBeat's FREE daily newsletter.

TCDA Stock News Headlines

Patrick G Enright's Net Worth
Elon’s $2 trillion dollar budget cut
Donald J. Trump will once again be President of the United States of America. And there is one man we have to thank for his efforts in getting him there. I am, of course, talking about President Trump’s most high-profile and powerful ally in his election campaign: Elon Musk.
Tricida Inc (TCDAQ)
Firm Retention Summary: Tricida Inc.
Tricida Announces Third Quarter 2022 Financial Results
Tricida Provides Strategic Update
See More Headlines

TCDA Stock Analysis - Frequently Asked Questions

Tricida, Inc. (NASDAQ:TCDA) posted its earnings results on Monday, November, 8th. The company reported ($0.79) earnings per share for the quarter, missing the consensus estimate of ($0.70) by $0.09.

Tricida (TCDA) raised $175 million in an IPO on Thursday, June 28th 2018. The company issued 10,300,000 shares at $16.00-$18.00 per share. Goldman Sachs, J.P. Morgan and Cowen acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tricida investors own include Sorrento Therapeutics (SRNE), Alibaba Group (BABA), NIO (NIO), Pfizer (PFE), Energy Transfer (ET), Teladoc Health (TDOC) and Sesen Bio (SESN).

Company Calendar

Last Earnings
11/08/2021
Today
11/15/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TCDA
Fax
N/A
Employees
57
Year Founded
N/A

Profitability

Net Income
$-176,570,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
35,851,000
Market Cap
$6.01 million
Optionable
Not Optionable
Beta
0.22
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

This page (NASDAQ:TCDA) was last updated on 11/15/2024 by MarketBeat.com Staff
From Our Partners